Transaction · 0001415889-25-005059

RA CAPITAL MANAGEMENT, L.P.

RA CAPITAL MANAGEMENT, L.P., 10%, reported an open-market or private purchase at Solid Biosciences Inc. involving 3722085.000000 shares for an estimated $14996280.47. Reported holdings after the transaction were 3722085.000000 shares. A 10b5-1 reference was not detected in the stored filing text.

Open-market buySEC transaction code P10%
SLDBSolid Biosciences Inc.
Filing timeFeb 21
Trade dateFeb 19, 2025
Filing · SECView on SEC
InsiderProfile

Price performance since filing

Close on the filing date, the pre-filing context, and the forward return at standard windows
Price at filing
…
Pre-filing
…
Returns since
…

SLDB price since this filing

30 days of pre-filing context and vertical markers at the filing date plus 7d / 30d / 90d / 180d / 1y afterwards
SLDB since 2025-02-21Filed 565 days ago · 30 days of pre-filing context shaded
Loading…
Filing datePost-filing windows (7d, 30d, 90d, 180d, 1y)30 days of pre-filing context

Transaction facts

Stored Form 4 columns with their raw values

Derivative
Type
Buy
Code P
Identifier
0001415889-25-005059
Pre-Funded Warrants (Right to Buy)
Transaction date
Feb 19, 2025
Filed Feb 21, 2025, 09:11 PM · 2d delay
Shares
3.72M sh
$403 per share
Estimated value
$1.49B
Computed from shares × price
Holdings after
3.72M sh
Indirect · See footnotes

Filing signal explanations

Badges describe filing facts only — not predictions.

Cluster 14dRepeat 30dPattern $10.0MLarge $100M
Cluster Buy Derivative Transaction Large Buy Large Holdings Increase 10% Owner Buy
+36score
Filing-only score

+36

Compact filing score computed from stored Form 4 facts. Version v1.

Strong filing signal

This filing has a high positive filing-only score. It may deserve closer research, but it is not an investment recommendation.

Reported relationships & other filings

Form 4 relationship flags and nearby filing context

Reported roles

No officer title

Officer NoDirector No10% YesOther No
Footnotes & amended
  1. F1

    The Pre-Funded Warrants have no expiration date and are exercisable immediately. Notwithstanding the foregoing, the Reporting Persons shall not be entitled to exercise the Pre-Funded Warrant if it wou…

  2. following such exercise.

  3. F2

    RA Capital Management, L.P. (the "Adviser") is the investment manager for RA Capital Healthcare Fund, L.P. (the "Fund") and RA Capital Nexus Fund, L.P. (the "Nexus Fund"). The general partner of the A…

  4. F3

    Held directly by the Fund.

Original filing · 0001415889-25-005059
Related transactions

0 other filings

Same reporting owner
Recent company activity

0 recent txs

SLDB